Amarin(AMRN.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Amarin
AMRN.US
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd.
1.878 T
AMRN.USMarket value -Rank by Market Cap -/-

Financial Score

13/06/2026 Update
C
BiotechnologyIndustry
Industry Ranking127/390
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-7.28%D
    • Profit Margin-15.51%D
    • Gross Margin39.37%B
  • Growth ScoreC
    • Revenue YoY1.24%C
    • Net Profit YoY61.77%B
    • Total Assets YoY-1.51%D
    • Net Assets YoY-5.12%D
  • Cash ScoreD
    • Cash Flow Margin-76.09%E
    • OCF YoY1.24%C
  • Operating ScoreD
    • Turnover0.33D
  • Debt ScoreB
    • Gearing Ratio30.41%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Hikma comments on Supreme Court of the United States' unanimous decision in favour of Hikma | HIK Stock News

    StockTitan·
    UK
    HIK
    0.00%
    StockTitan·
    UK
    HIK
    0.00%

    Sector Update: Healthcare Stocks Climb Late Afternoon

    Fidelity·
    US
    LLY
    -2.41%
    US
    UNH
    +0.73%
    US
    MRK
    -1.42%
    Fidelity·
    US
    LLY
    -2.41%
    US
    UNH
    +0.73%
    US
    MRK
    -1.42%

    Update: Supreme Court Rules Against Amarin in 'Skinny Label' Patent Case

    Fidelity·
    US
    AMRN
    +2.28%
    UK
    HIK
    0.00%
    Fidelity·
    US
    AMRN
    +2.28%
    UK
    HIK
    0.00%

    Amarin Presents RW-ApoB As Risk Identifier For Cardiovascular Disease Based On REDUCE-IT Data

    nasdaq·
    US
    AMRN
    +2.28%
    nasdaq·
    US
    AMRN
    +2.28%

    Amarin Shareholders Reject Dilution, Governance Proposals at AGM

    Tip Ranks·
    US
    AMRN
    +2.28%
    Tip Ranks·
    US
    AMRN
    +2.28%
    © 2026 Longbridge｜Disclaimer